Terazosin Hydrochloride NDC 24689-001

Product information

Brand name (proprietary)

Terazosin Hydrochloride

Generic name (nonproprietary)

terazosin hydrochloride

Active ingredients

Terazosin hydrochloride — 1 mg/1

Dosage form

Capsule

Route

Oral

Labeler

Apnar Pharma LP

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 074823

Marketing start

Aug 7, 2026

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic alpha-Antagonists (Mechanism)

Identifiers

Product ID 24689-001_3c52c76c-d0ca-46e7-bd3c-6192b20c995dSPL ID 3c52c76c-d0ca-46e7-bd3c-6192b20c995dSPL set ID 619dd5cb-46fb-4ad9-a05f-f064261a636bRxCUI 260376, 313215, 313217, 313219UNII D32S14F082

Pharmacologic class

alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424689000101 followed by a unit qualifier and the quantity Copy

Package 24689-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 074823

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.